SCHEMBL7073059

SCHEMBL7073059

C=C(C)COc1ccc(C(=O)C=Cc2c(Cl)cccc2Cl)c2oc3ccccc3c(=O)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
LMNA P02545 3/20 0.38
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
BLM P54132 1/20 0.38
KMT2A Q03164 1/20 0.38
MCL1 Q07820 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
STAT3 P40763 1/20 0.38
MAOA P21397 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7072633 0.84 MAOA (0.42) KDM4EALDH1A1LMNAMAPTTP53
SCHEMBL7128865 0.71 CA12 (0.50) KDM4EALDH1A1LMNAMAPTMEN1
SCHEMBL7184162 0.69 MAOA (0.52) KDM4EALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL2260240 0.63 CYP19A1 (0.47) KDM4EALDH1A1LMNAMAOANPC1
SCHEMBL6859087 0.63 MAOA (0.60) KDM4EALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL18593317 0.61 ABCG2 (0.66) MAOBABCG2
SCHEMBL9835732 0.61 TTR (0.48) KDM4EALDH1A1NPSR1HPGDHTT
SCHEMBL1225499 0.61 PTGS1 (0.58) KDM4EALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL1225500 0.61 PTGS1 (0.58) KDM4EALDH1A1LMNAPOLBSMN1; SMN2
SCHEMBL9837083 0.61 ALDH1A1 (0.54) KDM4EALDH1A1LMNAPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620842-B2 Chalcones INDENA SPA (IT) 2003-09-16 US disclosed
EP-1212315-B1 NOVEL CHALCONES INDENA SPA (IT) 2003-03-26 EP disclosed
US-20030055056-A1 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth INDENA S.P.A. (IT) 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055056-A1 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth HDGF, MKI67, HPD KDM4E 397/4885ALDH1A1 2113/4885LMNA 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.